Angiodynamics (ANGO) Deferred Taxes (2010 - 2026)
Angiodynamics' (ANGO) quarterly Deferred Taxes came in at $150000.0 in Q2 2026, up 177.72% on a YoY basis from $54011.2 in Q2 2025, and up 163.16% quarter-over-quarter from $57000.0 in Q1 2026.
Powered by 
Analysis
Angiodynamics (ANGO) Deferred Taxes (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has reported Deferred Taxes for 17 consecutive years, with $150000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Deferred Taxes rose 177.72% year-over-year to $150000.0; the trailing twelve-month figure through May 2026 stood at $143000.0 (up 114.47% YoY), and the FY2026 full-year result was $143000.0, up 114.47% from the prior year.
- Deferred Taxes climbed to $150000.0 in Q2 2026 per ANGO's latest filing, from $57000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $16.4 million in Q4 2023 and bottomed at -$12.1 million in Q1 2024.
- Historically, Deferred Taxes has averaged -$698500.0 across 5 years, with a median of -$294000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Deferred Taxes surged 2748.22% in 2023, then tumbled 5227.75% in 2024.
- Over 5 years, Deferred Taxes stood at -$618000.0 in 2022, then soared by 2748.22% to $16.4 million in 2023, then sank by 101.52% to -$249000.0 in 2024, then surged by 80.72% to -$48000.0 in 2025, then jumped by 412.5% to $150000.0 in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $150000.0, $57000.0, and -$48000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.32 Bn | 122.10 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 103.97 Bn | 100.50 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 63.66 Bn | 63.12 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.04 Bn | 30.09 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn | 600,000.00 |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn | 150,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 150,000.00 |
| Feb 28, 2026 | 57,000.00 |
| Nov 30, 2025 | -48,000.00 |
| Aug 31, 2025 | -16,000.00 |
| May 31, 2025 | -193,000.00 |
| Feb 28, 2025 | -207,000.00 |
| Nov 30, 2024 | -249,000.00 |
| Aug 31, 2024 | -339,000.00 |
| May 31, 2024 | -825,000.00 |
| Feb 29, 2024 | -12.09 Mn |
| Nov 30, 2023 | 16.37 Mn |
| Aug 31, 2023 | -11.42 Mn |
| May 31, 2023 | -559,000.00 |
| Feb 28, 2023 | -227,000.00 |
| Nov 30, 2022 | -618,000.00 |
| Aug 31, 2022 | -907,000.00 |
| May 31, 2022 | -587,000.00 |
| Feb 28, 2022 | -862,000.00 |
| Nov 30, 2021 | -569,000.00 |
| Aug 31, 2021 | -1.69 Mn |